Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 51.29

+0.3%

11:03 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LLCF who wrote (86)	3/18/1999 2:28:00 PM
From: LLCF	Read Replies (1) of 52153

Comp #Sh(mil) $(mil) $/shr Price Cap(mil)%$/Val 98'Exp* Revs* OSIP 21.40 $22 1.04 3.5 $75 30% 31.0 19.5 BTRN 8.58 $20 2.33 2.25 $19 104% 17.2 8.0 CEPH 28.73 $60 2.09 10 $287 21% 74.6 15.6 CORR 24.40 $50 2.05 8.5 $207 24% 73.2 41.9 TTP 13.10 $14 1.07 4 $52 27% MLNM 34.22 $150 4.38 34 $1,163 13% 139.0 133.7 INCY 29.34 $110 3.75 23 $675 16% 133.0 134.8 MBIO 19.60 $57 2.91 5 $98 58% 18.7 8.1 AXPH 30.00 $75 2.50 4 $120 63% 203.6 47.4 SIBI 9.00 $22 2.44 5 $45 49% annual due ONXX 11.42 $20 1.75 6 $69 29% 30.6 11.3 LGND 35.00 $41 1.17 9 $315 13% annual due GLFD 19.56 $120 6.14 10.5 $205 58% 50.3 12.5 GLIA 10.12 $27 2.62 23 $233 11% 22.0 17.3 NPSP 12.50 $40 3.20 6.5 $81 49% 23.4 3.6 CTII 18.41 $12 0.65 1.5 $28 43% 22.3 8.8 CELG 16.45 $18 1.06 13 $214 8% annual due PARS 37.00 $4 0.11 1.25 $46 9% 6.1 1.5 ALKS 24.90 $171 6.87 30 $747 23% 45.9 40.0 MEDX 31.30 $30 0.96 3.5 $110 27% 29.2 6.7 GELX 16.02 $110 6.87 17 $272 40% 41.1 32.7 PGNS 17.16 $65 3.79 40 $686 9% 62.6 61.1 CGPI 8.58 $10 1.17 10 $86 12% 16.0 3.0 NBIX 18.78 $59 3.14 6 $113 52% 28.5 16.0 PCOP 20.24 $52 2.57 9 $182 29% 105.7 92.2 PDLI 18.58 $140 7.53 16 $297 47% 40.0 30.0 VRTX 25.35 $245 9.67 26.5 $672 36% 77.5 44.5 CLTR 17.30 $130 7.52 23.5 $407 32% 40.0 34.0 *Revs & Exp in Millions ALKS 9 month data,SIBI lawsuit not included,LGND warrants not incl. AXPH had 124.888 mill. Aquired R&D expenses. GLFD stock buyback not included,CEPH recent financing not included. Update... DAK

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next